{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:37:27Z","timestamp":1793813847183,"version":"4.6.1"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite the fact that 1-year graft and recipient survival rates are above 90% in most transplant centers, improving long-term graft survival remains an important challenge. Immunosuppressant nonadherence has been recognized as one of the important risk factors for long-term graft failure. Understanding the modifiable correlates and risk factors for medication non-adherence is essential to develop interventions to improve adherence and thus long-term transplantation outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study conducted a questionnaire survey on 431 renal transplant recipients who were followed up in the outpatient clinic between January 2022 and January 2023, and 409 valid questionnaires were returned. The BAASIS questionnaire was used to assess the prevalence of nonadherence to immunosuppressive therapy (implementation phase) in Chinese renal transplant recipients and to explore the multilevel correlates of immunosuppressive nonadherence. The BAASIS questionnaire was used to categorize renal transplant recipients into adherent (n = 239) and non-adherent (n = 170) groups, and a prospective cohort study with a 1-year follow-up was conducted to explore the impact of immunosuppressant non-adherence on clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The prevalence of nonadherence to immunosuppressant therapy in renal transplant recipients in this study was as high as 41.6%. The number of years post-transplant (OR: 1.240, 95% CI: 1.136\u20131.353,\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001) and the frequency of twice-daily dosing (OR: 5.145, 95% CI: 2.690\u20139.840,\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001) were positively correlated with immunosuppressive nonadherence. There was a significant difference in TAC IPV (Intra-individual Variability) between the adherent and nonadherent groups (22.7 \u00b1 8.7 vs. 25.4 \u00b1 11.6,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.010). Renal function remained stable during the follow-up period in the recipients in the adherence group and tended to decrease in the recipients in the non-adherence group (F = 4.932,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.001). The rates of graft loss (7.1% vs. 1.7%,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.006) and rejection (12.4% vs. 4.2%,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.002) were higher in the nonadherent group than in the adherent group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Longer time post-transplant and higher frequency of immunosuppressive dosing were positively associated with nonadherence to immunosuppressives medication. Immunosuppressant nonadherence was associated with adverse graft outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2024.1493166","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T01:45:33Z","timestamp":1734486333000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Immunosuppressant nonadherence profile in kidney transplant recipients and the impact of medication adherence on transplant outcomes"],"prefix":"10.3389","volume":"15","author":[{"given":"Zou","family":"Zhi-yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Lin-rui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen-zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Ren-jie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Fei-hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Wei-jie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"B1","unstructured":"2024"},{"key":"B3","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1007\/s11096-017-0436-4","article-title":"Factors relevant to medication non-adherence in kidney transplant: a systematic review","volume":"39","author":"Belaiche","year":"2017","journal-title":"Int. J. Clin. Pharm."},{"key":"B4","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1177\/0193945911434518","article-title":"An ecological perspective on medication adherence","volume":"34","author":"Berben","year":"2012","journal-title":"J. Nurs. Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1547-5069.2003.tb00001.x","article-title":"Adherence to long-term therapies: evidence for action","volume":"35","author":"Burkhart","year":"2003","journal-title":"J. Nurs. Scholarsh."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.2147\/PPA.S383243","article-title":"Follow-up factors contribute to immunosuppressant adherence in kidney transplant recipients","volume":"16","author":"Chen","year":"2022","journal-title":"Patient Prefer Adherence"},{"key":"B7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.kint.2019.01.033","article-title":"Post-transplant donor specific antibody is associated with poor kidney transplant outcomes only when combined with both T-cell-mediated rejection and non-adherence","volume":"96","author":"Cherukuri","year":"2019","journal-title":"Kidney Int."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1111\/ajt.14611","article-title":"Multilevel factors are associated with immunosuppressant nonadherence in heart transplant recipients: the international BRIGHT study","volume":"18","author":"Denhaerynck","year":"2018","journal-title":"Am. J. Transpl."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1097\/TP.0000000000004574","article-title":"Psychometric properties of the BAASIS: a meta-analysis of individual participant data","volume":"107","author":"Denhaerynck","year":"2023","journal-title":"Transplantation"},{"key":"B10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12882-024-03620-z","article-title":"Medication non-adherence and its associated factors among kidney transplant patients in a large teaching hospital in Ethiopia","volume":"25","author":"Derejie","year":"2024","journal-title":"BMC Nephrol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1097\/01.tp.0000258599.65257.a6","article-title":"Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation","volume":"83","author":"Dew","year":"2007","journal-title":"Transplantation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/TP.0b013e3181e346cd","article-title":"The psychometric properties and practicability of self-report instruments to identify medication nonadherence in adult transplant patients: a systematic review","volume":"90","author":"Dobbels","year":"","journal-title":"Transplantation"},{"key":"B13","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.healun.2017.01.007","article-title":"Efficacy of a medication adherence enhancing intervention in transplantation: the MAESTRO-Tx trial","volume":"36","author":"Dobbels","year":"2017","journal-title":"J. Heart Lung Transpl."},{"key":"B14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/j.1399-3046.2010.01299.x","article-title":"Adherence to the immunosuppressive regimen in pediatric kidney transplant recipients: a systematic review","volume":"14","author":"Dobbels","year":"","journal-title":"Pediatr. Transplant."},{"key":"B15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/TP.0b013e31829b7571","article-title":"Medication adherence assessment: high accuracy of the new Ingestible Sensor System in kidney transplants","volume":"96","author":"Eisenberger","year":"2013","journal-title":"Transplantation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1097\/TP.0000000000004575","article-title":"BAASIS for monitoring therapy nonadherence in clinical transplantation: are we there yet?","volume":"107","author":"Elias","year":"2023","journal-title":"Transplantation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"l2378","DOI":"10.1136\/bmj.l2378","article-title":"Enhancing financial protection under China's social health insurance to achieve universal health coverage","volume":"365","author":"Fang","year":"2019","journal-title":"Bmj"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1093\/ckj\/sfac017","article-title":"Detecting, preventing and treating non-adherence to immunosuppression after kidney transplantation","volume":"15","author":"Gandolfini","year":"2022","journal-title":"Clin. Kidney J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"100511","DOI":"10.1016\/j.trre.2019.100511","article-title":"Medication non-adherence after kidney transplantation: a critical appraisal and systematic review","volume":"34","author":"Gokoel","year":"2020","journal-title":"Transpl. Rev. Orl."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1111\/ajt.16002","article-title":"A comprehensive review of the impact of tacrolimus intrapatient variability on clinical outcomes in kidney transplantation","volume":"20","author":"Gonzales","year":"2020","journal-title":"Am. J. Transpl."},{"key":"B21","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/tri.13412","article-title":"Evaluation of tools for annual capture of adherence to immunosuppressive medications after renal transplantation - a single-centre open prospective trial","volume":"32","author":"Gustavsen","year":"2019","journal-title":"Transpl. Int. official J. Eur. Soc. Organ Transplant."},{"key":"B22","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am. J. Transpl."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1097\/TP.0000000000004431","article-title":"Kidney-transplanted adolescents-nonadherence and graft outcomes during the transition phase: a nationwide analysis, 2000-2020","volume":"107","author":"Kindem","year":"2023","journal-title":"Transplantation"},{"key":"B24","doi-asserted-by":"publisher","first-page":"5397","DOI":"10.1038\/s41598-021-84868-5","article-title":"Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipients","volume":"11","author":"Ko","year":"2021","journal-title":"Sci. Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/13548506.2019.1622745","article-title":"Medication nonadherence after kidney transplantation: an internet-based survey in Japan","volume":"25","author":"Kobayashi","year":"2020","journal-title":"Psychol. Health Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"973564","DOI":"10.3389\/fphar.2022.973564","article-title":"Comparison of different methods to assess tacrolimus concentration intra-patient variability as potential marker of medication non-adherence","volume":"13","author":"Kostalova","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"217047","DOI":"10.1155\/2015\/217047","article-title":"Medication adherence measures: an overview","volume":"2015","author":"Lam","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1111\/ajt.15199","article-title":"Assessment of tacrolimus intrapatient variability in stable adherent transplant recipients: establishing baseline values","volume":"19","author":"Leino","year":"2019","journal-title":"Am. J. Transpl."},{"key":"B29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2174\/1874434601206010041","article-title":"Self-reported non-adherence and beliefs about medication in a Swedish kidney transplant population","volume":"6","author":"Lennerling","year":"2012","journal-title":"Open Nurs. J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/ajt.16982","article-title":"OPTN\/SRTR 2020 annual data report: kidney","volume":"22","author":"Lentine","year":"2022","journal-title":"Am. J. Transpl."},{"key":"B31","doi-asserted-by":"publisher","first-page":"08005","DOI":"10.7189\/jogh.11.08005","article-title":"Measuring and evaluating progress towards universal health coverage in China","volume":"11","author":"Liu","year":"2021","journal-title":"J. Glob. Health"},{"key":"B32","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1471-2369-14-108","article-title":"Transcultural adaptation and initial validation of Brazilian-Portuguese version of the Basel assessment of adherence to immunosuppressive medications scale (BAASIS) in kidney transplants","volume":"14","author":"Marsicano","year":"2013","journal-title":"BMC Nephrol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"11308","DOI":"10.3389\/ti.2023.11308","article-title":"Prevalence and patient-level correlates of intentional non-adherence to immunosuppressive medication after heart-transplantation-findings from the international BRIGHT study","volume":"36","author":"Marston","year":"2023","journal-title":"Transpl. Int. official J. Eur. Soc. Organ Transplant."},{"key":"B34","doi-asserted-by":"publisher","first-page":"92","DOI":"10.23736\/S2724-6051.21.04244-2","article-title":"Non-adherence assessment to immunosuppressant therapy with a self-report questionnaire and intra-patient variability in renal transplantation: risk factors and clinical correlations","volume":"75","author":"Mella","year":"2023","journal-title":"Minerva Urol. Nephrol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s40620-016-0273-x","article-title":"Nonadherence to immunosuppressive therapy in kidney transplant recipients: can technology help?","volume":"29","author":"Nerini","year":"2016","journal-title":"J. Nephrol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"S1-S56","DOI":"10.1097\/TP.0000000000001651","article-title":"Practical recommendations for long-term management of modifiable risks in kidney and liver transplant recipients: a guidance report and clinical checklist by the consensus on managing modifiable risk in transplantation (COMMIT) group","volume":"101","author":"Neuberger","year":"2017","journal-title":"Transplantation"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1681\/ASN.2017020216","article-title":"Understanding medication nonadherence after kidney transplant","volume":"28","author":"Nevins","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.asjsur.2019.07.011","article-title":"Improvement of medication adherence with simplified once-daily immunosuppressive regimen in stable kidney transplant recipients: a prospective cohort study","volume":"43","author":"Oh","year":"2020","journal-title":"Asian J. Surg."},{"key":"B39","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jpsychores.2015.09.001","article-title":"Physician reported adherence to immunosuppressants in renal transplant patients: prevalence, agreement, and correlates","volume":"79","author":"Pabst","year":"2015","journal-title":"J. Psychosom. Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00228-019-02643-y","article-title":"Reduction of exposure to tacrolimus trough level variability is associated with better graft survival after kidney transplantation","volume":"75","author":"Rahamimov","year":"2019","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1097\/TP.0000000000001040","article-title":"Within-patient variability in tacrolimus blood levels predicts kidney graft loss and donor-specific antibody development","volume":"100","author":"Rodrigo","year":"2016","journal-title":"Transplantation"},{"key":"B42","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/ajt.15528","article-title":"Improving medication adherence and outcomes in adult kidney transplant patients using a personal systems approach: SystemCHANGE\u2122 results of the MAGIC randomized clinical trial","volume":"20","author":"Russell","year":"2020","journal-title":"Am. J. Transpl."},{"key":"B43","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/TP.0000000000003214","article-title":"Multilevel correlates of immunosuppressive nonadherence in kidney transplant patients: the multicenter adhere Brazil study","volume":"105","author":"Sanders-Pinheiro","year":"2021","journal-title":"Transplantation"},{"key":"B44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12882-018-0840-6","article-title":"Prevalence and correlates of non-adherence to immunosuppressants and to health behaviours in patients after kidney transplantation in Brazil - the ADHERE Brazil multicentre study: a cross-sectional study protocol","volume":"19","author":"Sanders-Pinheiro","year":"2018","journal-title":"BMC Nephrol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1038\/ki.2013.465","article-title":"Time-dependent variability in tacrolimus trough blood levels is a risk factor for late kidney transplant failure","volume":"85","author":"Sapir-Pichhadze","year":"2014","journal-title":"Kidney Int."},{"key":"B46","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/j.1600-6143.2007.02127.x","article-title":"Diagnostic accuracy of measurement methods to assess non-adherence to immunosuppressive drugs in kidney transplant recipients","volume":"8","author":"Sch\u00e4fer-Keller","year":"2008","journal-title":"Am. J. Transpl."},{"key":"B47","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12882-017-0517-6","article-title":"Patient-reported non-adherence and immunosuppressant trough levels are associated with rejection after renal transplantation","volume":"18","author":"Scheel","year":"2017","journal-title":"BMC Nephrol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/JCN.0000000000000683","article-title":"Prevalence and correlates of cost-related medication nonadherence to immunosuppressive drugs after heart transplantation: the international multicenter cross-sectional bright study","volume":"35","author":"Sch\u00f6nfeld","year":"2020","journal-title":"J. Cardiovasc Nurs."},{"key":"B49","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/phar.2480","article-title":"Tacrolimus intrapatient variability in solid organ transplantation: a multiorgan perspective","volume":"41","author":"Schumacher","year":"2021","journal-title":"Pharmacotherapy"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1111\/ajt.14276","article-title":"The medication level variability index (MLVI) predicts poor liver transplant outcomes: a prospective multi-site study","volume":"17","author":"Shemesh","year":"2017","journal-title":"Am. J. Transpl."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2015.01.002","article-title":"Intra-patient variability in tacrolimus exposure: causes, consequences for clinical management","volume":"9","author":"Shuker","year":"","journal-title":"Transpl. Rev."},{"key":"B52","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.trre.2015.01.002","article-title":"Intra-patient variability in tacrolimus exposure: causes, consequences for clinical management","volume":"29","author":"Shuker","year":"","journal-title":"Transpl. Rev. Orl."},{"key":"B53","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/ctr.12283","article-title":"Determining the effect of immunosuppressant adherence on graft failure risk among renal transplant recipients","volume":"28","author":"Spivey","year":"2014","journal-title":"Clin. Transplant."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e002087","DOI":"10.1136\/bmjgh-2019-002087","article-title":"Towards universal health coverage: achievements and challenges of 10 years of healthcare reform in China","volume":"5","author":"Tao","year":"2020","journal-title":"BMJ Glob. Health"},{"key":"B55","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/jnu.12157","article-title":"Symptom experience associated with immunosuppressive medications in Chinese kidney transplant recipients","volume":"47","author":"Teng","year":"2015","journal-title":"J. Nurs. Scholarsh."},{"key":"B2","unstructured":"2024"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1111\/tri.13993","article-title":"Is simplification of immunosuppressive medication a way to promote medication adherence of kidney transplant recipients? Findings from a randomized controlled trial","volume":"34","author":"van Zanten","year":"2021","journal-title":"Transpl. Int. official J. Eur. Soc. Organ Transplant."},{"key":"B57","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1053\/j.ajkd.2021.12.013","article-title":"A cost-effectiveness analysis of adherence promotion strategies to improve rejection rates in adolescent kidney transplant recipients","volume":"80","author":"Varnell","year":"2022","journal-title":"Am. J. Kidney Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.pec.2019.08.002","article-title":"Adherence profiles in kidney transplant patients: causes and consequences","volume":"103","author":"Villeneuve","year":"2020","journal-title":"Patient Educ. Couns."},{"key":"B59","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","article-title":"A new taxonomy for describing and defining adherence to medications","volume":"73","author":"Vrijens","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/TP.0000000000001129","article-title":"High intrapatient tacrolimus variability is associated with worse outcomes in renal transplantation using a low-dose tacrolimus immunosuppressive regime","volume":"101","author":"Whalen","year":"2017","journal-title":"Transplantation"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1177\/10547738221096550","article-title":"Exploration of adherence to the immunosuppressive medication in kidney transplant recipients based on theory of planned behavior","volume":"31","author":"Yang","year":"2022","journal-title":"Clin. Nurs. Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12913-020-4960-x","article-title":"Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Health Serv. Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.transproceed.2017.03.086","article-title":"A study on adherence to follow-up, quality of life, and associated factors among renal transplant recipients in China","volume":"49","author":"Zhao","year":"2017","journal-title":"Transplant. Proc."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1493166\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T01:45:37Z","timestamp":1734486337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1493166\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":63,"alternative-id":["10.3389\/fphar.2024.1493166"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1493166","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"article-number":"1493166"}}